Health
Coronavirus Vaccine: Oxford University’s COVID-19 Vaccine Candidate Exhibits Strong Immune Responses, Says The Lancet Study | News – Swachh India NDTV
According to the data published in The Lancet, the first phase of human trial of the vaccine candidate ChAdOx1 nCoV-19 developed at the University of Oxford has shown encouraging results and appears to induce strong immune response within the body
Highlights
- Phase-I trial for the ChAdOx1 nCoV-19 vaccine involved 1,077 people
- The vaccine is made from a harmless chimpanzee virus
- The vaccine is able to generate both humoural and T-cells immunity response
New Delhi: The preliminary data of the COVID-19 candidate vaccine developed by the University of Oxford has shown encouraging results in first stage of the vaccine development. The study titled Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine aga…
Continue Reading